Conference abstractPublished 17 Oct 2016
Is PAI-1 good or bad? - Knockdown of PAI-1 in PANC-1 human pancreatic adenocarcinoma and in vitro invasiveness
Tel Aviv University Sackler Faculty of Medicine, Israel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is generally accepted that overexpression of plasminogen activator inhibitor 1 (PAI-1) correlates with worse prognosis and more invasive phenotype of many cancers, including pancreatic adenocarcinoma (PAC). We down-regulated PAI-1 expression in PANC-1 cells via shRNA knockdown (KD). The down-regulated variant (PD-PANC) exhibited neural morphological traits compared to cuboidal morphology of WT PANC-1s or vector-transfected cells. RT-PCR demonstrated that KD of PAI-1 leads to decreased expression of mesenchymal markers transcripts concurrently with increased expression of epithelial and neural transcripts, suggesting partial mesenchymal-to-epithelial transition. Importantly, PD-PANC1s expressed markedly more E-cadherin in a larger proportion of cells, whereas TUBB3 was expressed predominantly in cells with neural morphology. Despite this apparent more epithelial phenotype, PD-PANC-1s exhibited more invasive behavior in vitro. Although, the invading cells expressed more PAI-1 and less E-cadherin transcripts than non-invaders, it could not explain the observed increase in invasiveness. Using fluorescent supravital staining in a mixed vector/PD-PANC-1 population, we demonstrated that cells that down-regulated PAI-1 created environment promoting invasion of the few cells expressing high PAI-1 level. We previously reported that PD-PANCs exhibit higher uPA activity and continuously convert plasminogen to plasmin, which have been shown to activate matrix metalloproteinases. Indeed, inclusion of plasminogen enhanced invasion of PD-PANC-1s. In conclusion, our results suggest that fine balancing of different activities rather than extensive ablation of the “offending” PAI-1 protein maybe a better strategy in maintaining a less aggressive PAC phenotype.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Yoram Oron”